Antineoplastic indole-containing compounds with potential VEGFR inhibitory properties
DR Aboshouk, MA Youssef, MS Bekheit, AR Hamed… - RSC …, 2024 - pubs.rsc.org
Cancer is one of the most significant health challenges worldwide. Various techniques, tools
and therapeutics/materials have been developed in the last few decades for the treatment of …
and therapeutics/materials have been developed in the last few decades for the treatment of …
Role of heterocycles in inhibition of VEGFR-2–a recent update (2019–2022)
A Dorababu - RSC Medicinal Chemistry, 2024 - pubs.rsc.org
The literature reveals that oncogenic protein kinase inhibition has been proved to be a
successful anticancer approach. The vascular endothelial growth factor receptor (VEGFR) …
successful anticancer approach. The vascular endothelial growth factor receptor (VEGFR) …
New tolfenamic acid derivatives with hydrazine-1-carbothioamide and 1, 3, 4-oxadiazole moieties targeting VEGFR: synthesis, in silico studies, and in vitro anticancer …
VEGFR-2 is required for tumor angiogenesis and metastasis. As a cancer therapeutic
strategy, blocking VEGFR-2 signaling pathway has gained much interest. Our work aimed to …
strategy, blocking VEGFR-2 signaling pathway has gained much interest. Our work aimed to …
New Indole‐6‐Carboxylic Acid Derivatives as Multi‐Target Antiproliferative Agents: Synthesis, in Silico Studies, and Cytotoxicity Evaluation
Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor
(VEGFR) are commonly overexpressed in cancers making them appealing targets for cancer …
(VEGFR) are commonly overexpressed in cancers making them appealing targets for cancer …
In vitro and in silico evaluation of 4'-hydroxy-[1, 1'-biphenyl]-4-carbohydrazide Schiff base and oxadiazole derivatives targeting EGFR allosteric site
Inhibition of EGFR tyrosine kinase (TK) activity is considered a promising therapeutic
strategy for cancer treatment. Type I and II EGFR TK inhibitors bind the ATP-binding site …
strategy for cancer treatment. Type I and II EGFR TK inhibitors bind the ATP-binding site …
Anti-proliferation evaluation of new derivatives of indole-6-carboxylate ester as receptor tyrosine kinase inhibitors
Aim: The main goal was to create two new groups of indole derivatives, hydrazine-1-
carbothioamide (4a and 4b) and oxadiazole (5, and 6a–e) that target EGFR (4a, 4b, 5) or …
carbothioamide (4a and 4b) and oxadiazole (5, and 6a–e) that target EGFR (4a, 4b, 5) or …
Synthesis, In Silico Prediction, and In Vitro Evaluation of Anti-tumor Activities of Novel 4'-Hydroxybiphenyl-4-carboxylic Acid Derivatives as EGFR …
Introduction Allosteric inhibition of EGFR tyrosine kinase (TK) is currently among the most
attractive approaches for designing and develo** anti-cancer drugs to avoid …
attractive approaches for designing and develo** anti-cancer drugs to avoid …
DFT Computation, Spectroscopic, Hirshfeld Surface, Docking and Topological Analysis on 2, 2, 5‐Trimethyl‐1, 3‐Dioxane‐5‐Carboxylic Acid as Potent Anti‐Cancer …
ABSTRACT The 2, 2, 5‐trimethyl‐1, 3‐dioxane‐5‐carboxylic acid (TDCA) using both
theoretical and experimental methods have been studied. The sample has been subjected …
theoretical and experimental methods have been studied. The sample has been subjected …
Novel Tridentate Hydrazone of Heterocyclic N‐oxide and Its Transition Metal Complexes: Evaluation of DNA/BSA Binding Interactions, In Vitro and In Silico Biological …
S Deepa, A Nayakini, R Mudavath, PJ Lakshmi… - …, 2025 - Wiley Online Library
Abstract Novel hydrazone ligand 2‐(2‐(2‐hydroxy‐5‐methoxybenzylidene)
hydrazinecarbonyl) pyridine 1‐oxide was synthesized and characterized by spectral …
hydrazinecarbonyl) pyridine 1‐oxide was synthesized and characterized by spectral …
Identification of Phytochemical Inhibitors Targeting VEGFA and TGFBR2 of Cervical Cancer: Insights from Virtual Screening, ADMET and DFT Studies
The vascular endothelial growth factor A (VEGFA) and Transforming Growth Factor Beta
type II receptor (TGFBR2) serves as a promising candidate in the treatment of cervical …
type II receptor (TGFBR2) serves as a promising candidate in the treatment of cervical …